Caleres

Company CAL

Last mentioned: Mar 20, 2026

Timeline

  1. ASH Annual Meeting

    Curis targets presentation of initial proof-of-concept data for the CLL study.

  2. Torrid Store Closures

    Target date for an additional 30 store closures by Torrid to reach savings goals.

  3. Q4 Earnings Release

    Curis, Torrid, Caleres, and Lands' End all report Q4 2025 results.

  4. PIPE Financing

    Curis secured initial $20.2M in PIPE proceeds to fund oncology pipeline development.

  5. Erivedge Wind-down

    Royalties from Erivedge began winding down, prompting the strategic sale to Oberland.

Stories mentioning Caleres 1

funding Neutral

Curis Secures Oncology Runway as Macro Headwinds Pressure Retail Margins

Curis (CRIS) has successfully pivoted to a clinical-stage oncology focus, securing a cash runway into 2027 through a strategic asset sale and PIPE financing. Meanwhile, broader retail earnings from Torrid and Caleres reveal significant margin pressures from tariffs, signaling a complex macro environment for healthcare supply chains.

4 sources

About Caleres coverage

This page surfaces every story mentioning Caleres across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Caleres was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.